BACHRODT AMY (SVP, Finance) sold 27.8% of their position (5K shares) of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $226.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+5K
Price / share
$10.42
Trade value
$52.10K
% of position
Common Stock
Shares
−1.30K
Price / share
$44.44
Trade value
$57.77K
% of position
Common Stock
Shares
−3.70K
Price / share
$45.47
Trade value
$168.24K
% of position
Net shares
+0.00
Net value
-$173.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | M · Option Exercise | +5K | $10.42 | $52.10K | 38.6% | 12.96K | 17.96K |
| Common Stock Direct | 3/2/2026 | S · Sale | −1.30K | $44.44 | $57.77K | 7.2% | 17.96K | 16.66K |
| Common Stock Direct | 3/2/2026 | S · Sale | −3.70K | $45.47 | $168.24K | 22.2% | 16.66K | 12.96K |
| Total | +0.00 | -$173.91K | ||||||
Stock Option (Right to Buy)
Common Stock
5K shares
Shares
−5K
Strike price
10.42
Held after
36.33K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
32K shares
Shares
+32K
Strike price
45.61
Held after
32K
Exercisable
—
Restricted Stock Units
Common Stock
16K shares
Shares
+16K
Strike price
Held after
16K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5K shares | 3/2/2026 | M · Option Exercise | −5K | 10.42 | — | 36.33K |
| Stock Option (Right to Buy) Direct | Common Stock32K shares | 3/2/2026 | A · Award | +32K | 45.61 | — | 32K |
| Restricted Stock Units Direct | Common Stock16K shares | 3/2/2026 | A · Award | +16K | — | 16K |